Stryker Corporation

New York Stock Exchange
Back to all articles
Slightly Bullish +15

AdvisorShares Investments LLC Has $6.12 Million Stock Holdings in ...

📉 AdvisorShares Investments LLC reduced its Stryker position by 8.8% in Q1, selling 1,794 shares to retain a $6.12 million stake.

📈 Brighton Jones LLC increased its holding by 15.4%, while Marshall Wace LLP surged its position by 107.9% in the second quarter.

💰 New institutional buyers Schnieders Capital, Nebula Research, and HUB Investment Partners acquired stakes valued at approximately $677,000 combined.

📉 Vice Presidents M Kathryn Fink and Robert S. Fletcher sold 5,220 and 4,544 shares respectively under Rule 10b5-1 trading plans.

💸 Total insider selling reached 323,264 shares valued at $100.66 million over the last 90 days.

📊 Analyst consensus remains 'Moderate Buy' with an average price target of $395.33 despite recent downgrades from Wall Street Zen and Leerink Partners.

💵 Stryker declared a quarterly dividend of $0.88 per share, offering a 1.1% annualized yield to shareholders of record by June 30th.

📈 Financial metrics show a market cap of $125.13 billion, a P/E ratio of 37.78, and a healthy debt-to-equity ratio of 0.62.

📉 Stock price fluctuates between a twelve-month low of $281.00 and a high of $404.87 with a current fifty-day moving average of $309.80.

Bullish Signals
  • Marshall Wace LLP significantly increased its position by 107.9% in the second quarter, acquiring an additional 77,831 shares.
  • Brighton Jones LLC boosted its stake by 15.4%, adding 609 shares to its existing portfolio.
  • Three new institutional investors—Schnieders Capital Management, Nebula Research & Development, and HUB Investment Partners—initiated new positions totaling approximately $677,000.
  • The company maintains a strong balance sheet with a quick ratio of 1.25, current ratio of 2.11, and a low debt-to-equity ratio of 0.62.
  • Analysts maintain a 'Moderate Buy' consensus rating with an average price target of $395.33, indicating continued institutional interest.
Risk Factors
  • AdvisorShares Investments LLC reduced its position by 8.8% during the first quarter, signaling some institutional caution.
  • Recent analyst downgrades from Wall Street Zen and Leerink Partners suggest potential short-term pressure on the stock price.
  • Significant insider selling activity occurred in the last 90 days, with insiders offloading 323,264 shares valued at $100.66 million.
  • Vice Presidents M Kathryn Fink and Robert S. Fletcher reduced their personal holdings by 28.44% and 30.04% respectively.
Full Analysis
AdvisorShares Investments LLC reduced its position in Stryker Corporation (NYSE:SYK) by 8.8% during the first quarter, selling 1,794 shares to hold a remaining stake of 18,632 shares valued at $6.12 million. This reduction makes Stryker the firm's 25th largest holding, representing approximately 1.1% of its total portfolio as reported in recent SEC filings. Conversely, several other institutional investors and hedge funds increased their exposure to the medical technology company during the second and fourth quarters. Brighton Jones LLC boosted its position by 15.4%, while Marshall Wace LLP significantly increased its stake by 107.9% to own 5,700 shares valued at $2.255 million. Other new positions were acquired by Schnieders Capital Management, Nebula Research & Development, and HUB Investment Partners. The article details recent insider selling activity where Vice Presidents M Kathryn Fink and Robert S. Fletcher sold a combined total of 9,764 shares under pre-arranged Rule 10b5-1 trading plans. Additionally, sixteen equity research analysts currently rate the stock as a 'Moderate Buy' with an average price target of $395.33, though recent downgrades from Wall Street Zen and Leerink Partners have tempered expectations. Stryker Corporation reported a quarterly dividend of $0.88 per share payable on July 31st to stockholders of record as of June 30th, resulting in an annualized yield of 1.1%. The company maintains a market capitalization of $125.13 billion with a P/E ratio of 37.78 and a debt-to-equity ratio of 0.62, trading between a twelve-month low of $281.00 and a high of $404.87.